Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Inari Medical

evt | Article | October 2021

The Pursuit of Bloodless Thrombectomy

How Inari Medical’s purpose-built venous portfolio allows for complete thrombus extraction unimpeded by blood loss concerns.

With Duke Duncan, MD; Orestis Pappas, MD; Bennet George, MD; and Clarence Gill, MD

evt | Article | January 2006

Targeted Renal Therapy

A novel device holds promise in preventing and treating renal insufficiency.

By David E. Allie, MD; Barry S. Weinstock, MD; and Paul Teirstein, MD

evt | News | January 7, 2020

IceCure Receives FDA Clearance for Expanded Indications of Cryoablation Technology and Approval of MultiSense System

January 7, 2020—IceCure Medical Ltd. announced FDA clearance of expanded indications for the company’s cryoablation technology.

evt | News | July 9, 2019

FDA Clears Centerline's IOPS Intraoperative Positioning System

July 10, 2019—Centerline Biomedical, Inc. announced that the company has received FDA 510(k) clearance to market its IOPS intraoperative positioning system.

Advertisement

Advertisement

evt | News | September 13, 2022

Bentley Acquires the GoBack Catheter From Upstream Peripheral Technologies

September 13, 2022—Bentley, based in Hechingen, Germany, announced it has acquired the rights of the GoBack catheter from Upstream Peripheral Technologies, which is headquartered in Caesarea, Israel.

evt | News | December 9, 2020

FDA Clears Medical Ingenuities’ PH Band Radial Artery Occlusion Device

December 9, 2020—Medical Ingenuities’ radial artery occlusion device, PH Band, has received FDA 510(k) clearance.

evt | News | August 16, 2022

Vena Medical’s Balloon Distal Access Catheter Investigated in Canada With First-Ever Procedures

August 16, 2022—Vena Medical, a Canada-based developer of neurovascular devices, announced the successful treatment of the first five patients in the world using the Vena balloon distal access catheter (BDAC) at London Health Sciences Centre (LHSC) University Hospital in London, Ontario, and The Ottawa Hospital (TOH) in Ottawa, Ontario, Canada.

evt | News | July 16, 2017

Rapid Medical Receives Funding to Advance Commercialization of Stroke Treatment Devices

July 17, 2017—Rapid Medical, an Israel-based company focused on the development of neurovascular interventional devices, announced that it has completed a Series B financing of $9 million to advance the commercialization of the company's minimally invasive stroke treatment and prevention products, the Tigertriever revascularization device and the Comaneci adjustable remodeling mesh.

evt | News | September 11, 2019

FDA Clears Rex Medical's Revolution Peripheral Atherectomy System

September 12, 2019—Rex Medical, LP announced that it has received FDA 510(k) clearance for the Revolution peripheral atherectomy system.

evt | News | June 29, 2021

Ra Medical Announces Progress of the Next-Generation DABRA Excimer Laser System

June 29, 2021—Ra Medical Systems, Inc. announced that enrollment in the pivotal atherectomy clinical trial with its DABRA excimer laser system is now at 62 patients, including 42 patients enrolled since the beginning of 2021.

evt | News | March 5, 2017

2-Year ATTRACT Data: Anticoagulation Alone Best for Most DVT; PCDT Benefits Seen in Certain Iliofemoral Patients

March 6, 2017—The much-anticipated 2-year results from the ATTRACT study were presented by Suresh Vedantham, MD, FSIR, on behalf of the trial’s investigators, at the 2017 Society of Interventional Radiology (SIR) Annual Scientific Meeting.

evt | Article | April 2017

ATTRACT 2-Year Data and Commentary

Two-year ATTRACT data show that anticoagulation alone is best for most deep vein thrombosis; pharmacomechanical catheter-directed thrombolysis benefits seen in certain iliofemoral patients.

evt | Article | April 2025

An Interview With Vivian L. Bishay, MD

Dr. Bishay discusses the keys to a successful interventional radiology program, her role as National Co-Principal Investigator of SYMPHONY-PE and the broader clinical trial landscape for PE, priorities for women’s health research, and more.

evt | News | May 21, 2025

GE HealthCare CleaRecon DL for CBCT Imaging Launched in United States and Europe

May 21, 2025—GE HealthCare recently announced the launch of CleaRecon DL in the United States and European Union.

evt | News | February 12, 2024

InspireMD Announces PIs for C-GUARDIANS II Trial Evaluating the SwitchGuard Neuroprotection System

February 12, 2024—InspireMD, Inc. named Patrick Geraghty, MD, and Patrick Muck, MD, as the lead Principal Investigators (PIs) for the company’s upcoming C-GUARDIANS II clinical trial for the SwitchGuard neuroprotection system (NPS).  According to the company, the C-GUARDIANS II study will aim to advance clearance of SwitchGuard NPS and associated tools, which are designed to allow the treating physician to reverse cerebral blood flow during a transcarotid artery revascularization procedure, preventing embolic debris generated during the procedure from traveling to the brain by passing the blood through the filter enclosed within the SwitchGuard before returning it to the patient to minimize blood loss.

evt | Article | November 2003

The Importance of Renal Artery Stenting in Ischemic Nephropathy

Ischemic nephropathy is the most important indication for intervention in renal artery occlusive disease.

By Thomas A. Sos, MD, and David W. Trost, MD

Sponsored by Inari Medical

evt | Article | July 2021

Inari Medical Takes on Venous Thromboembolism in Europe

How single-session, thrombolytic-free mechanical thrombectomy is fundamentally changing the treatment of pulmonary embolism and deep vein thrombosis.

With Felix Mahfoud, MD, FESC; Andrew Wigham, BSc (Hons), MBBS (Lond), MRCS, FRCR; Emma Wilton, MB BChir, MA (Cantab), MD, FRCS; and Michael Piorkowski, MD

evt | News | June 21, 2018

Percutaneous AV Fistula Creation Systems Gain FDA Marketing Authorization

June 22, 2018—The US Food and Drug Administration has announced the marketing authorization of two systems designed to percutaneously create arteriovenous (AV) fistulas in hemodialysis patients.

evt | News | November 17, 2014

Zoll to Acquire Philips' InnerCool Business

November 17, 2014—Zoll Medical Corporation, an Asahi Kasei Group company, announced that it has signed an agreement to purchase substantially all of the assets of Royal Philips Electronics’ InnerCool temperature management business.

evt | News | September 30, 2021

Siemens Healthineers Naeotom Alpha Photon-Counting CT Technology Cleared by FDA

September 30, 2021—Siemens Healthineers announced FDA 510(k) clearance of the Naeotom Alpha, a photon-counting CT.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button